RxDoctor Payments Data

Barbara Haley

Hematology & Oncology · Dallas, TXNPI 1518936087

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $52 of the $64 with a category attached, or 81.5%. Puma Biotechnology, Inc. accounts for 81.5% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.

$64in general payments, 2019–2025

Across 2 payments — averaging $32.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Puma Biotechnology, Inc.$52
  • Gilead$12
$1,636,257in research payments, 2019–2025

Across 241 payments — averaging $6789.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Puma Biotechnology, Inc.$410K
  • Daiichi Sankyo Inc.$211K
  • Pfizer$189K
  • Seagen Inc.$157K
  • Eli Lilly$148K
  • Genentech, Inc.$117K
  • plus $405K from 9 others

What the payments were for

  • Food & beverage$5281%
  • Education$1219%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Puma Biotechnology, Inc.1$52
Gilead1$12

How this compares

$64 in reported general payments places this provider in the 5th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas →

Other hematology & oncology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →